This is a paid press release. Contact the press release distributor directly with any inquiries.
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center
Vivos Therapeutics, Inc
Fri, August 28, 2026 at 6:15 PM GMT+5:30
8 min read
- RDGL
+4.51% - VVOS
-12.96%
Physician-Aligned Collaboration to Support a Regional Sleep & Airway Medicine Center in Palm Beach County
LITTLETON, Colo., Aug. 28, 2026 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or “the Company”) (Nasdaq: VVOS), a leading medical device and healthcare services company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from obstructive sleep apnea (“OSA”) and other health conditions related to breathing and sleep disorders, today announced the execution of definitive collaboration and operating agreements with South Palm Cardiovascular Associates, LLC (“SPCVA”) to support the establishment and operation of a regional Sleep & Airway Medicine Center (“SAMC”) in Palm Beach County, Florida.
The definitive agreements build on the collaboration announced on June 10, 2026, and provide the framework for the formation, capitalization, governance and operation of AIM Florida, LLC (“AIM Florida”), a physician-aligned management services organization, including management services arrangements with affiliated clinical entities. Vivos expects to hold a 75% majority of the membership and economic interests in AIM Florida, subject to applicable regulatory requirements and the terms of the definitive agreements.
The parties are evaluating several potential locations and negotiating a lease for the initial facility. Subject to site selection, lease execution, build-out, licensing, payer enrollment, staffing and other customary startup requirements, the center is expected to begin treating patients and generating revenue in the first quarter of 2027
The operating plan calls for an initial fully staffed Sleep Optimization Team capable of serving approximately 250 patients per month. Based on its operating experience in Las Vegas and current assumptions, Vivos believes the initial team, once fully deployed, can generate up to $6 million in annual revenue with contribution margins of 30% or more. Additional teams may be added as demand develops. SPCVA doctors and staff will work to expand the referral base to include other local medical practices treating patients with similar sleep disorder issues.
SPCVA is a multi-location, physician-owned cardiology practice with approximately 30,000 patients of record. Its cardiologists have long recognized the serious health challenges that undiagnosed and untreated OSA can present for patients with cardiovascular disease and have sought more reliable access to comprehensive sleep testing and treatment services in their market
